Didier Laeckmann
Company Owner at Indépendant | Arrondissement of Tongeren, Flemish Region, Belgium
Didier Laeckmann’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Company Owner at Indépendant in January 2013 - Present
Gerant Pharmawatch at Indépendant in September 2013 - Present
Freelance Quality Consultant chez Sanofi pour le compte de CitWell at Sanofi in November 2024 - February 2025
Support Qualité Reception, Commissionning & Qualification at Oril Industries in June 2024 - August 2024
Chargé d’Assurance Stérilité at Servier in June 2023 - March 2024
QMS, Documentation and Training Head at Orgenesis Inc. in December 2022 - July 2023
SPOC Moderna at Recipharm in May 2022 - July 2022
Change Control Lead at Sanofi in January 2022 - May 2022
SPOC BionTECH at DELPHARM SAINT REMY in September 2021 - December 2021
Quality and Compliance Support Manager at MSD Türkiye in November 2020 - September 2021
GMP Mentor & Leadership at GSK in July 2020 - November 2020
Process-Expert & Compliance at MaSTherCell-Catalent Cell and Therapy in March 2020 - June 2020
CPV Project Leader at Altran in January 2020 - February 2020
QA Process Manager/Process Project Lead at Healthcare Business of Merck in April 2019 - December 2019
Quality Director, Head of Quality Assurance, Quality Control and Compliance (Manager de transition) at MSD France in May 2018 - January 2019
Production Support at ALK in November 2017 - February 2018
Senior Deviations Investigator & Reviewer at Genethon in August 2017 - October 2017
Deviations, Investigations & CAPA Senior Reviewer at LFB in May 2017 - August 2017
Senior Quality Expert at Sanofi Pasteur in September 2014 - April 2017
Process Expert at Allergopharma GmbH & Co. KG in July 2014 - September 2014
Aseptic Mentor & Coach - Senior External Advisor at GSK Vaccines at GSK in January 2014 - July 2014
Senior cGMP Compliance Expert at GSK in April 2013 - December 2013
Associate Director Finished Dosage Forms & Medical Devices at UCB Pharma in April 2011 - December 2012
Director New Product Introduction & Process Validation at Catalent Pharma Solutions in May 2007 - April 2011
Senior Project Leader/Coordinator at NextPharma in May 2005 - May 2007
Project Coordinator/Leader at NextPharma in June 2003 - April 2005
Ph.D Researcher- Assistant University at Therabel Research/University of Liège in October 1998 - May 2003
R&D project Leader at Therabel Research in February 1993 - September 1998
Teacher at Institut Saint-Vincent de Paul, Uccle in March 1992 - September 1992
University of Liège, January 1986 to January 1989
Orgenesis is a global biotech company that has been committed to unlocking the potential of decentralized cell and gene therapies (CGTs) since 2012. Orgenesis established the POCare Network in 2020 to bring academia, hospitals, and Industry together to make these innovations more affordable and accessible to patients. In 2022, the POCare Services business unit responsible for developing and managing the decentralized POCare Centers and proprietary OMPULs was formed. Orgenesis will continue to focus on advancing to market through various partnerships its CGTs to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production.
Discover more about Indépendant
Director, Scientific Marketing
Scientific Marketing Director at Orgenesis Inc.
(March 2022 – Present)
Project Manager and Team Leader at Orgenesis Inc.
Project Manager and team leader at Orgenesis Biotech Israel Ltd (formerly known as ATVIO)
(March 2021 – Present)
CFO. Orgenesis LTD. Strategic financial leadership in global, high growth environments
Member of executive management team.
Leads an international staff of CPA s and accountants.
Spearheaded financial due diligence for investments and fundraising ( > $150 million raised).
Manages all finance related functions including SEC reporting (10K, 10Q, 8K, S3, etc.) acco...
Delivering advanced personalized cell and gene therapies (CGTs) therapies to market effectively.
Orgenesis is a pioneering global biotech company featuring a unique Cell & Gene Therapy Biotech Platform. The company is focused on unlocking the power of cell and gene therapies with this platform to provide life changing treatments at the Point of Care (POCare) to large numb...
Senior HR Executive | People Champion | Strategic Leadership | Talent Strategy | Global Head of Human Resources at Orgenesis Inc.
• Spearheaded the establishment of the HR function at Orgenesis Inc. within three months.
• Oversaw global HR operations across 12 entities in the US, Europe, and Asia.
• Developed comprehensive talent acquisition strategies, enhancing recruitment efficiency.
• Imp...
Ph.D. | Global Senior Director – Analytical Development & QC/CMC | Cell & Gene Therapy Innovator | 15+ Years Leading QC, Assay Development & Tech Transfer teams
*Led global QC operations, standardizing protocols across multiple sites to ensure regulatory compliance and consistency throughout the product lifecycle.
*Developed and validated innovative potency assays for MSCs and CAR-T products, cutting assay costs by 70% and improving t...
What is Didier Laeckmann email address?
Email Didier Laeckmann at [email protected], [email protected] and [email protected]. This email is the most updated Didier Laeckmann's email found in 2026.
What is Didier Laeckmann phone number?
Didier Laeckmann phone number is 0032497591026.
How to contact Didier Laeckmann?
To contact Didier Laeckmann send an email to [email protected], [email protected] or [email protected]. If you want to call Didier Laeckmann try calling on 0032497591026.
What company does Didier Laeckmann work for?
Didier Laeckmann works for Indépendant.
What is Didier Laeckmann's role at Indépendant?
Didier Laeckmann is Company Owner
What industry does Didier Laeckmann work in?
Didier Laeckmann works in the Pharmaceuticals industry.
